He was followed by serial echos and had increasing DOE with CHF.
Cath revealed 80% OM 1, 80% OM 2, RCA 90%.
Prior echo showed marked LVH, EF 60-65%, severe AS, mild to moderate MR, mild TR, [**Doctor Last Name **].
Past Medical History: 1) HTN 2) Hyperlipidemia 3) Gout 4) Aortic stenosis - ECHO [**2177-6-19**] (1.1 area, 24 mean gradient) 5) CRI PSHX 1) Cataract surgery 2) Knee arthroscopy ONCOLOGIC HISTORY: [**2171**] - Mr. [**Known lastname 64996**] presented with hematuria and clot retention.
A  CT scan revealed a 7 cm x 6 cm x 5 cm left renal clear cell cancer with focal sarcomatoid features, grade III-IV with no capsular perivascular, or renal vein invasion.
[**2177-10-27**] - underwent superficial parotidectomy and pathology was consistent with metastatic renal cell carcinoma.
Pulses: 2+ bilat Fem/DP/PT/Radial Neuro: nonfocal exam, alert and oriented x 3  Discharge VS: 98.8  71SR  100/56  18   92%/RA Gen: NAD Neuro: A&Ox3 nonfocal Pulm: CTA bilat CV: RRR Sternum stable, incision CDI Abdm: soft, NT/ND/+BS Ext: warm, trace edema bilat   Pertinent Results: [**2179-6-21**] 06:30AM BLOOD WBC-6.6 RBC-3.03* Hgb-9.8* Hct-28.5* MCV-94 MCH-32.2* MCHC-34.2 RDW-15.2 Plt Ct-170# [**2179-6-21**] 06:30AM BLOOD Plt Ct-170# [**2179-6-20**] 06:15AM BLOOD Glucose-114* UreaN-22* Creat-1.5* Na-132* K-4.0 Cl-93* HCO3-31 AnGap-12 [**2179-6-20**] 06:15AM BLOOD Calcium-8.5 Phos-4.3 Mg-2.4 [**2179-6-16**] 01:55PM BLOOD %HbA1c-5.9 Hematology Test Name Value Units Reference Range [**2179-6-24**] 07:05AM BASIC COAGULATION (PT, PTT, PLT, INR) PT 14.6* sec 10.4 - 13.1   PERFORMED AT WEST STAT LAB INR(PT) 1.3*   0.9 - 1.1   PERFORMED AT WEST STAT LAB Test Name Value Units Reference Range [**2179-6-24**] 07:05AM RENAL & GLUCOSE Glucose 97 mg/dL 70 - 105   PERFORMED AT WEST STAT LAB Urea Nitrogen 28* mg/dL 6 - 20   PERFORMED AT WEST STAT LAB Creatinine 1.6* mg/dL 0.5 - 1.2   PERFORMED AT WEST STAT LAB Sodium 135 mEq/L 133 - 145   PERFORMED AT WEST STAT LAB Potassium 4.8 mEq/L 3.3 - 5.1   PERFORMED AT WEST STAT LAB Chloride 98 mEq/L 96 - 108   PERFORMED AT WEST STAT LAB Bicarbonate 29 mEq/L 22 - 32   PERFORMED AT WEST STAT LAB Anion Gap 13 mEq/L 8 - 20 ESTIMATED GFR (MDRD CALCULATION) Estimated GFR (MDRD equation)   Using this patient's age, gender, and serum creatinine value of 1.6, Estimated GFR = 43 if non African-American (mL/min/1.73 m2) Estimated GFR = 52 if African-American (mL/min/1.73 m2) For comparison, mean GFR for age group 60-69 is 85 (mL/min/1.73 m2) GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure  Cardiology Report ECHO Study Date of [**2179-6-17**]  PATIENT/TEST INFORMATION: Indication: avr/cabg Status: Inpatient Date/Time: [**2179-6-17**] at 09:24 Test: TEE (Complete) Doppler: Full Doppler and color Doppler Contrast: None Tape Number: 2007AW1-: Test Location: Anesthesia West OR cardiac Technical Quality: Adequate  REFERRING DOCTOR: DR. [**First Name11 (Name Pattern1) 1112**] [**Initial (NamePattern1) **].
[**Last Name (NamePattern1) **] MEASUREMENTS: Left Ventricle - Inferolateral Thickness: *1.2 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: 5.5 cm (nl <= 5.6 cm) Left Ventricle - Ejection Fraction: 50% to 55% (nl >=55%) Aorta - Ascending: 3.2 cm (nl <= 3.4 cm) Aorta - Descending Thoracic: 2.4 cm (nl <= 2.5 cm) Aortic Valve - Peak Gradient: 54 mm Hg Aortic Valve - LVOT Diam: 1.9 cm Aortic Valve - Valve Area: *0.6 cm2 (nl >= 3.0 cm2) Mitral Valve - Mean Gradient: 3 mm Hg Mitral Valve - MVA (P [**12-22**] T): 4.7 cm2  INTERPRETATION: Findings: LEFT ATRIUM: No spontaneous echo contrast is seen in the LAA.
LV WALL MOTION: basal anterior - normal; mid anterior - normal; basal anteroseptal - normal; mid anteroseptal - normal; basal inferoseptal - normal; mid inferoseptal - normal; basal inferior - normal; mid inferior - normal; basal inferolateral - normal; mid inferolateral - normal; basal anterolateral - normal; mid anterolateral - normal; anterior apex - normal; septal apex - normal; inferior apex - normal; lateral apex - normal; apex - normal; RIGHT VENTRICLE: Normal RV chamber size and free wall motion.
GENERAL COMMENTS: A TEE was performed in the location listed above.
FINDINGS: Comparison is made to the previous study from [**2179-6-18**].
DR. [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) **] Approved: SUN [**2179-6-20**] 2:40 PM      Brief Hospital Course: Admitted [**6-16**] and cath done revealing AS and CAD.
Underwent AVR/cabg x1 with Dr. [**Last Name (STitle) **] on [**6-17**].
Over the next several days the patients activity was advanced, his INR monitored and coumadin dose adjusted.
His INR is to be followed by [**Name (NI) 64998**] coumadin clinic, 1st visit Monday [**6-28**].
lipids left knee gout prior knee arthroscopy prior bil.cataract surgeries prior left carpal tunnel surgery prior left parotidectomy with Cyberknife radiation   Discharge Condition: stable   Discharge Instructions: Weigh yourself every morning, [**Name8 (MD) 138**] MD if weight > 3 lbs.
